These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30075517)

  • 21. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.
    Jackson AM; Petrie MC; Frogoudaki A; Laroche C; Gustafsson F; Ibrahim B; Mebazaa A; Johnson MR; Seferovic PM; Regitz-Zagrosek V; Mbakwem A; Böhm M; Prameswari HS; Fouad DA; Goland S; Damasceno A; Karaye K; Farhan HA; Hamdan R; Maggioni AP; Sliwa K; Bauersachs J; van der Meer P;
    Eur J Heart Fail; 2021 Dec; 23(12):2058-2069. PubMed ID: 34114268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripartum cardiomyopathy: definition, incidence, etiopathogenesis, diagnosis, and management.
    Garg J; Palaniswamy C; Lanier GM
    Cardiol Rev; 2015; 23(2):69-78. PubMed ID: 25111318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry.
    Jackson AM; Goland S; Farhan HA; Yaseen IF; Prameswari HS; Böhm M; Jhund PS; Maggioni AP; van der Meer P; Sliwa K; Bauersachs J; Petrie MC
    Eur Heart J; 2024 Apr; 45(16):1430-1439. PubMed ID: 38282532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis.
    Duncker D; Westenfeld R; Konrad T; Pfeffer T; Correia de Freitas CA; Pfister R; Thomas D; Fürnkranz A; Andrié RP; Napp A; Schmitt J; Karolyi L; Wakili R; Hilfiker-Kleiner D; Bauersachs J; Veltmann C
    Clin Res Cardiol; 2017 Aug; 106(8):582-589. PubMed ID: 28275862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incident stroke in individuals with peripartum cardiomyopathy.
    Ibeh C; Kulick ER; Boehme AK; Friedman AM; Miller EC; Bello NA
    Am Heart J; 2024 Sep; 275():138-140. PubMed ID: 38908422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Recognition and Treatment for the Optimal Care of Individuals With Peripartum Cardiomyopathy.
    LeBlanc CA; Johnson K
    Nurs Womens Health; 2022 Aug; 26(4):308-317. PubMed ID: 35714761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripartum cardiomyopathy: A systematic review of the literature.
    Asad ZUA; Maiwand M; Farah F; Dasari TW
    Clin Cardiol; 2018 May; 41(5):693-697. PubMed ID: 29749620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute kidney injury predicts poor left ventricular function for patients with peripartum cardiomyopathy.
    Zhu J; Liu W
    BMC Cardiovasc Disord; 2021 Apr; 21(1):205. PubMed ID: 33888084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers.
    Azibani F; Pfeffer TJ; Ricke-Hoch M; Dowling W; Pietzsch S; Briton O; Baard J; Abou Moulig V; König T; Berliner D; Libhaber E; Schlothauer S; Anthony J; Lichtinghagen R; Bauersachs J; Sliwa K; Hilfiker-Kleiner D
    ESC Heart Fail; 2020 Apr; 7(2):512-522. PubMed ID: 32064780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison and analysis of different diagnostic criteria for peripartum cardiomyopathy].
    Wang Y; Gao Z; Liu GL; Wei J; Zhang XH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):487-91. PubMed ID: 22041438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation Therapy in Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy.
    Kido K; Guglin M
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):31-36. PubMed ID: 29911432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non-African American Women.
    Irizarry OC; Levine LD; Lewey J; Boyer T; Riis V; Elovitz MA; Arany Z
    JAMA Cardiol; 2017 Nov; 2(11):1256-1260. PubMed ID: 29049825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Libhaber E; Labidi S; Fischer D; Roentgen P; Tsikas D; Jordan J; Lichtinghagen R; von Kaisenberg CS; Struman I; Bovy N; Sliwa K; Bauersachs J; Hilfiker-Kleiner D
    Basic Res Cardiol; 2013 Jul; 108(4):366. PubMed ID: 23812247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Nonhoff J; Ricke-Hoch M; Mueller M; Stapel B; Pfeffer T; Kasten M; Scherr M; von Kaisenberg C; Bauersachs J; Haghikia A; Hilfiker-Kleiner D
    Cardiovasc Res; 2017 May; 113(6):598-608. PubMed ID: 28453725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline Characteristics and Clinical Insights from the ARTEMIS Registry: A Comprehensive Study of Peripartum Cardiomyopathy in Türkiye.
    Kayıkçıoğlu M; Biteker M; Mutluer FO; Güzel T; Yılmaz E; Demir E; Nalbantgil S; Ertaş F; Çiçek Yılmaz D; Temizhan A; Aşkın L; Dinç Asarcıklı L; Akçay M; Demirbağ R; Köroğlu S; Örnek E; Çelik A; Akıl MA; Arslan B; Tokgözoğlu L;
    Turk Kardiyol Dern Ars; 2024 Oct; 52(7):474-483. PubMed ID: 39397413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
    Farhan HA; Yaseen IF
    ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy.
    Li W; Li H; Long Y
    Can J Cardiol; 2016 Mar; 32(3):362-8. PubMed ID: 26586094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.
    Goland S; Bitar F; Modi K; Safirstein J; Ro A; Mirocha J; Khatri N; Elkayam U
    J Card Fail; 2011 May; 17(5):426-30. PubMed ID: 21549301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta-analysis.
    Hosseinpour A; Hosseinpour H; Kheshti F; Abdollahifard S; Attar A
    ESC Heart Fail; 2022 Oct; 9(5):3483-3495. PubMed ID: 35883253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.
    Damp J; Givertz MM; Semigran M; Alharethi R; Ewald G; Felker GM; Bozkurt B; Boehmer J; Haythe J; Skopicki H; Hanley-Yanez K; Pisarcik J; Halder I; Gorcsan J; Rana S; Arany Z; Fett JD; McNamara DM;
    JACC Heart Fail; 2016 May; 4(5):380-8. PubMed ID: 26970832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.